
Coronary Stent Thrombosis With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial
Keywords: از; antiplatelet therapy; atherothrombosis; DES; PAR-1; stent; thienopyridine; ACS; acute coronary syndrome(s); ADP; adenosine diphosphate; ARC; Academic Research Consortium; CI; confidence interval; DAPT; dual antiplatelet therapy; DES; drug-eluting stent(s)